$86 Million

Quotient Limited

Follow-on Offering

Bookrunner, September 2020

Quotient Limited, Inc. is a commercial-stage diagnostics company dedicated to manufacturing transfusion diagnostic equipment and test kits. MosaiQ, the Company’s lead product, is a proprietarily developed and automated testing platform designed to deliver immunohematology (blood grouping) (IH) and serological disease screening (SDS). We are also developing a third microarray for molecular disease screening (MDS). The MosaiQ facilitates an extensive antigen typing/antibody identification of donor and patient blood through the use of a single microarray. The MosaiQ instrument has been designed to process up to 3,000 microarrays per day, giving a capacity to test up to 1,500 donor samples (utilizing both IH and SDS microarrays) or 3,000 patient samples. Each MosaiQ microarray can host up to 132 probes, and the MosaiQ instrument can deliver test results every 24 seconds after the instrument is fully loaded.

More Like This

Sep 2020
$80 Million

Follow-on Offering

Lead Left Bookrunner

View Details
Sep 2020
$150 Million

Follow-on Offering

Lead Left Bookrunner

View Details
Sep 2020
$287 Million

Follow-on Offering

Bookrunner

View Details